Author Interview: Pamiparib and TMZ in recurrent IDHmt gliomas episode artwork

EPISODE · Feb 2, 2026 · 23 MIN

Author Interview: Pamiparib and TMZ in recurrent IDHmt gliomas

from Neuro-Oncology: The Podcast · host Drs. Iyad Alnahhas, David Schiff, Ranjit Bindra

Dr. Iyad Alnahhas interviews Drs. David Schiff and Ranjit Bindra about their recent manuscript entitled "Phase I/II and Window-of-Opportunity Study of Pamiparib and Metronomic Temozolomide for Recurrent IDH Mutant Gliomas", published online in Neuro-Oncology in October 2025.

NOW PLAYING

Author Interview: Pamiparib and TMZ in recurrent IDHmt gliomas

0:00 23:18

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Neuro-Oncology: The Podcast?

This episode is 23 minutes long.

When was this Neuro-Oncology: The Podcast episode published?

This episode was published on February 2, 2026.

What is this episode about?

Dr. Iyad Alnahhas interviews Drs. David Schiff and Ranjit Bindra about their recent manuscript entitled "Phase I/II and Window-of-Opportunity Study of Pamiparib and Metronomic Temozolomide for Recurrent IDH Mutant Gliomas", published online in...

Can I download this Neuro-Oncology: The Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!